Skip to content

Study · Animal study (in vivo) · calf · 1998

1 result

Small intestinal morphology in eight-day-old calves fed colostrum for different durations or only milk replacer and treated with long-R3-insulin-like growth factor I and growth hormone.

Bühler C, Hammon H, Rossi GL, Blum JW

Journal of animal science1 Mar 1998Cited by 70 (Europe PMC)

PMID9535335 (opens in a new tab)DOI10.2527/1998.763758x (opens in a new tab)PepBankPUB-09535335
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In newborn calves, Long-R3-IGF-I given subcutaneously or orally for 7 days had no significant influence on small intestinal morphology.

    In plain wordsIn newborn calves, Long-R3-IGF-I had no significant effect on the structure of the small intestine.

    Peptide
    IGF-1 LR3
    Outcome
    No significant changeSmall intestinal mucosal morphology
    Study

    calfn: not reported in source

    newborn calves
    Outcome group
    Intestinal growth and absorption · Gastrointestinal
    Studied dose
    50 microg/[kg BW x d] · subcutaneous or oral · 7 dAs given in this study (calf).

    Source sentences

    Summary
    In contrast, Long-R3-IGF-I had no significant influence on small intestinal morphology
    1 context sentence
    Summary · context
    The effects of feeding different amounts of colostrum or only milk replacer and the effects of Long-R3-IGF-I (administered s.c. or orally; 50 microg/[kg BW x d] for 7 d), and of s.c. injected recombinant bovine GH (rbGH; 1 mg/[kg BW x d] for 7 d) on small intestinal mucosal morphology in newborn cal…

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.